Apr 28Leadership & CorporateMablink, in the supplement of the March 2023 issue of "La Jaune et la Rouge"Interview with Jean-Guillaume LAFAY, CEO of Mablink, in the supplement of the March 2023 issue of "La Jaune et la Rouge" on the topic...
Mar 14Science & MedicineMablink Bioscience to Present Promising Preclinical Data for Lead ADC Candidate MBK-103 at the AACRMablink's poster will include in vivo efficacy data in mouse models and safety data in non-human primates
Jan 20Science & MedicineA new review on the history and future of ADC payloads published by Mablink’s scientistsMablink announces the publication of a review article titled “Payload diversification: a key step in the development of antibody–drug...